GLORIA

GEOMAR Library Ocean Research Information Access

X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Material
Publisher
Person/Organisation
Language
Years
FID
Subjects(RVK)
  • 1
    Online Resource
    Online Resource
    Gallstone‐induced acute pancreatitis
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 60-69
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 60-69
    Abstract: In the care of acute pancreatitis, a prompt search for the etiologic condition of the disease should be conducted. A differentiation of gallstone‐induced acute pancreatitis should be given top priority in its etiologic diagnosis because it is related to the decision of treatment policy. Examinations necessary for diagnosing gallstone‐induced acute pancreatitis include blood tests and ultrasonography. Early ERCP/ES should be performed in patients with gallstone‐induced acute pancreatitis if a complication of cholangitis and a prolonged passage disorder of the biliary tract are suspected. The treatment for bile duct stones with the use of ERCP/ES alone is not recommended in cases of gallstone‐induced pancreatitis with gallbladder stones. Cholecystectomy for gallstone‐induced acute pancreatitis should be performed using a laparoscopic procedure as the first option as soon as the disease has subsided.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0217-0
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 2
    Online Resource
    Online Resource
    Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 37-44
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 37-44
    Abstract: The assessment of severity at the initial medical examination plays an important role in introducing adequate early treatment and the transfer of patients to a medical facility that can cope with severe acute pancreatitis. Under these circumstances, “criteria for severity assessment” have been prepared in various countries, including Japan, and these criteria are now being evaluated. The criteria for severity assessment of acute pancreatitis in Japan were determined in 1990 (of which a partial revision was made in 1999). In 2008, an overall revision was made and the new Japanese criteria for severity assessment of acute pancreatitis were prepared. In the new criteria for severity assessment, the diagnosis of severe acute pancreatitis can be made according to 9 prognostic factors and/or the computed tomography (CT) grades based on contrast‐enhanced CT. Patients with severe acute pancreatitis are expected to be transferred to a specialist medical center or to an intensive care unit to receive adequate treatment there. In Japan, severe acute pancreatitis is recognized as being a specified intractable disease on the basis of these criteria, so medical expenses associated with severe acute pancreatitis are covered by Government payment.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0213-4
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 3
    Online Resource
    Online Resource
    Changes in management of acute pancreatitis before and after the publication of evidence‐based practice guidelines in 2003
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 17-23
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 17-23
    Abstract: The Japanese Guidelines for the Management of Acute Pancreatitis was published in 2003. However, the impact of the guidelines on physicians’ practice patterns has not been well known. Methods To examine the current clinical practices in the management of acute pancreatitis, we conducted a questionnaire survey with members of three societies involved in the treatment of pancreatic diseases and abdominal emergency medical care. Questions included diagnostic and treatment processes considered important in the management of acute pancreatitis in addition to demographic data, experience in medical care, and areas of specialty of respondents. We also examined changes in the treatment of acute pancreatitis before and after publication of the Guidelines. Results Of 1,000 society members to whom questionnaires were mailed, 590 responded. Respondents who had read the Guidelines also handled significantly more cases in the most recent 3 years. A variety of changes were observed in the performance of clinical practices before and after publication of the Guidelines. The use of amylase in the assessment of severity decreased significantly, while its use for determination of severity scores increased significantly after publication of the Guidelines. In treatment, use of a nasogastric tube in mild and moderate cases deceased after the Guidelines. The frequency of prophylactic use of antibiotics decreased with mild pancreatitis after publication of the Guidelines. Conclusions Although it is difficult to attribute these changes to the direct influence of the Guidelines, several changes were observed in performance of clinical practices in accordance with recommendations of the Guidelines.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0212-5
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 4
    Online Resource
    Online Resource
    Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial
    Springer Science and Business Media LLC ; 2020
    In:  Journal of Gastroenterology Vol. 55, No. 3 ( 2020-03), p. 342-352
    Details
    In: Journal of Gastroenterology, Springer Science and Business Media LLC, Vol. 55, No. 3 ( 2020-03), p. 342-352
    Abstract: Continuous regional arterial infusion (CRAI) of protease inhibitor nafamostat mesilate (NM) is used in the context of predicted severe acute pancreatitis (SAP) to prevent the development of pancreatic necrosis. Although this therapy is well known in Japan, its efficacy and safety remain unclear. Methods This investigator-initiated and -driven, multicenter, open-label, randomized, controlled trial (UMIN000020868) enrolled 39 patients with predicted SAP and low enhancement of the pancreatic parenchyma on computed tomography (CT). Twenty patients were assigned to the CRAI group, while 19 served as controls and were administered NM at the same dose intravenously (IV group). The primary endpoint was the development of pancreatic necrosis as determined by CT on Day 14, judged by blinded central review. Results There was no difference between the CRAI and IV groups regarding the percentages of participants who developed pancreatic necrosis (more than 1/3 of the pancreas: 25.0%, range 8.7–49.1% vs. 15.8%, range 3.4–39.6%, respectively, P  = 0.694; more than 2/3 of the pancreas: 20%, range 5.7–43.7% vs. 5.3%, range 0.1–26.0%, respectively, P  = 0.341). The early analgesic effect was evaluated based on 24-h cumulative fentanyl consumption and additional administration by intravenous patient-controlled analgesia. The results showed that the CRAI group used significantly less analgesic. There were two adverse events related to CRAI, namely bleeding and splenic infarction. Conclusions CRAI with NM did not inhibit the development of pancreatic necrosis although early analgesic effect of CRAI was superior to that of IV. Less-invasive IV therapy can be considered a viable alternative to CRAI therapy.
    Type of Medium: Online Resource
    ISSN: 0944-1174 , 1435-5922
    URL: Article
    DOI: 10.1007/s00535-019-01644-z
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 1473159-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 5
    Online Resource
    Online Resource
    New diagnostic criteria of acute pancreatitis
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 24-36
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 24-36
    Abstract: Practical guidelines for the diagnosis of acute pancreatitis are presented so that a rapid and adequate diagnosis can be made. When acute pancreatitis is suspected in patients with acute onset of abdominal pain and tenderness mainly in the upper abdomen, the diagnosis of acute pancreatitis is made on the basis of elevated levels of pancreatic enzymes in the blood and/or urine. Furthermore, other acute abdominal diseases are ruled out if local findings associated with pancreatitis are confirmed by diagnostic imaging. According to the diagnostic criteria established in Japan, patients who present with two of the following three manifestations are diagnosed as having acute pancreatitis: characteristic upper abdominal pain, elevated levels of pancreatic enzymes, and findings of ultrasonography (US), CT or MRI suggesting acute pancreatitis. Detection of elevated levels of blood pancreatic enzymes is crucial in the diagnosis of acute pancreatitis. Measurement of blood lipase is recommended, because it is reported to be superior to all other pancreatic enzymes in terms of sensitivity and specificity. For measurements of the blood amylase level widely used in Japan, it should be cautioned that, because of its low specificity, abnormal high values are also often obtained in diseases other than pancreatitis. The cut‐off level of blood pancreatic enzymes for the diagnosis of acute pancreatitis is not able to be set because of lack of sufficient evidence and consensus to date. CT study is the most appropriate procedure to confirm image findings of acute pancreatitis. Elucidation of the etiology of acute pancreatitis should be continued after a diagnosis of acute pancreatitis. In the process of the etiologic elucidation of acute pancreatitis, judgment whether it is gallstone‐induced or not is most urgent and crucial for deciding treatment policy including the assessment of whether endoscopic papillary treatment should be conducted or not. The diagnosis of gallstone‐induced acute pancreatitis can be made by combining detection of elevated levels of bilirubin, transamylase (ALT, AST) and ALP detected by hematological examination and the visualization of gallstones by US.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0214-3
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 6
    Online Resource
    Online Resource
    Pancreatitis bundles
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 87-89
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 87-89
    Abstract: Clinical indicators set forth in the guidelines have been found to contribute to the improvement in compliance with the guidelines. On the other hand, it has been shown that clinical indicators are more effective when individual indicators are presented in the form of a bundle than when they are given separately. Accordingly, in the JPN Guidelines 2010 for management of acute pancreatitis, those indicators that are judged to be important on the basis of a recommendation classification of “A or B” are presented as a pancreatitis bundle. Each item includes assessment of severity after a diagnosis of pancreatitis has been made, differentiation of pathogenesis, management of gallstone‐induced pancreatitis, a sufficient dose of fluid replacement and monitoring, pain control, prophylactic administration of wide‐spectrum antibiotics and cholecystectomy following resolution of pancreatic symptoms caused by cholecystolithiasis. Hereafter, the efficacy of these indicators and the significance of their achievement should be examined carefully. Then, the assessment of the compliance rate with the guidelines as well as the assessment of the guidelines and pancreatitis itself should become possible.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0219-y
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 7
    Online Resource
    Online Resource
    Fundamental and intensive care of acute pancreatitis
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 45-52
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 45-52
    Abstract: Patients who have been diagnosed as having acute pancreatitis should be, on principle, hospitalized. Crucial fundamental management is required soon after a diagnosis of acute pancreatitis has been made and includes monitoring of the conscious state, the respiratory and cardiovascular system, the urinary output, adequate fluid replacement and pain control. Along with such management, etiologic diagnosis and severity assessment should be conducted. Patients with a diagnosis of severe acute pancreatitis should be transferred to a medical facility where intensive respiratory and cardiovascular management as well as interventional treatment, blood purification therapy and nutritional support are available. The disease condition in acute pancreatitis changes every moment and even symptoms that are mild at the time of diagnosis may become severe later. Therefore, severity assessment should be conducted repeatedly at least within 48 h following diagnosis. An adequate dose of fluid replacement is essential to stabilize cardiovascular dynamics and the dose should be adjusted while assessing circulatory dynamics constantly. A large dose of fluid replacement is usually required in patients with severe acute pancreatitis. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with severe acute pancreatitis. Although the efficacy of intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional continuous regional arterial infusion and blood purification therapy.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0210-7
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 8
    Online Resource
    Online Resource
    Consensus in initial management of acute pancreatitis (3rd Edition)
    Japan Pancreas Society ; 2011
    In:  Suizo Vol. 26, No. 6 ( 2011), p. 651-683
    Details
    In: Suizo, Japan Pancreas Society, Vol. 26, No. 6 ( 2011), p. 651-683
    Type of Medium: Online Resource
    ISSN: 0913-0071 , 1881-2805
    Uniform Title: 急性膵炎における初期診療のコンセンサス 改訂第3版
    URL: Article
    DOI: 10.2958/suizo.26.651
    Language: Japanese , Japanese
    Publisher: Japan Pancreas Society
    Publication Date: 2011
    detail.hit.zdb_id: 2433526-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 9
    Online Resource
    Online Resource
    Post‐ERCP pancreatitis
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 70-78
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 70-78
    Abstract: Pancreatitis remains the most common severe complication of endoscopic retrograde cholangiopancreatography (ERCP). Detailed information about the findings of previous studies concerning post‐ERCP pancreatitis has not been utilized sufficiently. The purpose of the present article was to present guidelines for the diagnostic criteria of post‐ERCP pancreatitis, and its incidence, risk factors, and prophylactic procedures that are supported by evidence. To achieve this purpose, a critical examination was made of the articles on post‐ERCP pancreatitis, based on the data obtained by research studies published up to 2009. At present, there are no standardized diagnostic criteria for post‐ERCP pancreatitis. It is appropriate that post‐ERCP pancreatitis is defined as acute pancreatitis that has developed following ERCP, and its diagnosis and severity assessment should be made according to the diagnostic criteria and severity assessment of the Japanese Ministry of Health, Labour and Welfare. The incidence of acute pancreatitis associated with diagnostic and therapeutic ERCP is 0.4–1.5 and 1.6–5.4%, respectively. Endoscopic papillary balloon dilation is associated with a high risk of acute pancreatitis compared with endoscopic sphincterotomy. It was made clear that important risk factors include dysfunction of the Oddi sphincter, being of the female sex, past history of post‐ERCP pancreatitis, and performance of pancreaticography. Temporary prophylactic placement of pancreatic stents in the high‐risk group is useful for the prevention of post‐ERCP pancreatitis [odds ratio (OR) 3.2, 95% confidence interval (CI) 1.6–6.4, number needed to treat (NNT) 10]. Use of nonsteroidal anti‐inflammatory drugs (NSAIDs) is associated with a reduction in the development of post‐ERCP pancreatitis (OR 0.46, 95% CI 0.32–0.65). Single rectal administration of NSAIDs is useful for the prevention of post‐ERCP pancreatitis [relative risk (RR) 0.36, 95% CI 0.22–0.60, NNT 15] and decreases the development of pancreatitis in both the low‐risk group (RR 0.29, 95% CI 0.12–0.71) and the high‐risk group (RR 0.40, 95% CI 0.23–0.72) of post‐ERCP pancreatitis. As for somatostatin, a bolus injection may be most useful compared with short‐ or long‐term infusion (OR 0.271, 95% CI 0.138–0.536, risk difference 8.2%, 95% CI 4.4–12.0%). The usefulness of gabexate mesilate was not apparent in any of the following conditions: acute pancreatitis (control 5.7 vs. 4.8% for gabexate mesilate), hyperamylasemia (40.6 vs. 36.9%), and abdominal pain (1.7 vs. 8.9%). Formulation of diagnostic criteria for post‐ERCP pancreatitis is needed. Temporary prophylactic placement of pancreatic stents in the high‐risk group offers the most promise as a means of preventing post‐ERCP pancreatitis. As for pharmacological attempts, there are high expectations concerning NSAIDs because they are excellent in terms of cost‐effectiveness, ease of use, and safety. There was no evidence of effective prophylaxis with the use of protease inhibitors, especially gabexate mesilate.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0220-5
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 10
    Online Resource
    Online Resource
    Cutting‐edge information for the management of acute pancreatitis
    Wiley ; 2010
    In:  Journal of Hepato-Biliary-Pancreatic Sciences Vol. 17, No. 1 ( 2010-01), p. 3-12
    Details
    In: Journal of Hepato-Biliary-Pancreatic Sciences, Wiley, Vol. 17, No. 1 ( 2010-01), p. 3-12
    Abstract: Considering that the Japanese (JPN) guidelines for the management of acute pancreatitis were published in Takada et al. (J HepatoBiliary Pancreat Surg 13:2–6, 2006), doubts will be cast as to the reason for publishing a revised edition of the Guidelines for the management of acute pancreatitis: the JPN guidelines 2010, at this time. The rationale for this is that new criteria for the severity assessment of acute pancreatitis were made public on the basis of a summary of activities and reports of shared studies that were conducted in 2008. The new severity classification is entirely different from that adopted in the 2006 guidelines. A drastic revision was made in the new criteria. For example, about half of the cases that have been assessed previously as being ‘severe’ are assessed as being ‘mild’ in the new criteria. The JPN guidelines 2010 are published so that consistency between the criteria for severity assessment in the first edition and the new criteria will be maintained. In the new criteria, severity assessment can be made only by calculating the 9 scored prognostic factors. Severity assessment according to the contrast‐enhanced computed tomography (CT) grade was made by scoring the poorly visualized pancreatic area in addition to determining the degree of extrapancreatic progress of inflammation and its extent. Changes made in accordance with the new criteria are seen in various parts of the guidelines. In the present revised edition, post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is treated as an independent item. Furthermore, clinical indicators (pancreatitis bundles) are presented to improve the quality of the management of acute pancreatitis and to increase adherence to new guidelines.
    Type of Medium: Online Resource
    ISSN: 1868-6974 , 1868-6982
    URL: Article
    DOI: 10.1007/s00534-009-0216-1
    Language: English
    Publisher: Wiley
    Publication Date: 2010
    detail.hit.zdb_id: 2536390-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...